A first approach to identifying cardiotoxic effects of breast cancer chemotherapeutic treatment in Kazakhstan Article Swipe
Saule Balmagambetova
,
Zhenisgul Tlegenova
,
Bekbolat Zholdin
,
Gulnara Kurmanalina
,
Iliada Talipova
,
Arip Koyshybaev
,
Ainel Urazova
,
Dinara Nurmanova
,
Olzhas Urazayev
,
Gulmira Sultanbekova
,
Kulparshan Kubenova
,
Mira Baspayeva
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.23950/jcmk/11412
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.23950/jcmk/11412
As known, the clinical efficacy of chemotherapy is limited by the cardiotoxicity of drugs used. The study aimed to clarify cardiotoxic complications of chemotherapy from the Aktobe Medical Center database for 2018-2019. Material and methods: We performed a register study on essential parameters of the oncological process, drugs used, duration of chemotherapy, types of complications, and outcomes, including survival. Results: We found a total of 305 breast cancer cases. Chemotherapy was completed without complications in 65.9% of patients; treatment was interrupted due to complications - 10.5%; 6.2% of cardiovascular complications were identified. The two groups of patients, EchoCG + and EchoCG -, showed significant difference in the number of detected CV complications (p<.001) but no difference in the survival rate (p .814). The survival rate in patients with documented CV complications was 28.1 months vs. 34.3 months in the group without ones (p.005). The survival rate in those who completed the treatment without complications, was 34.9 months vs. 17.6 in individuals whose treatment was interrupted due to complications (p<.001). We performed a detailed review of four cases of cardiotoxicity with fatal outcomes. Conclusion: The analysis indicates the absence of a systematic approach to recording crucial information regarding cardiotoxicity. There is a lack of concordance in the actions of cardiologists and oncologists in the management of BC patients. The presence of lethal outcomes of chemotherapy with an established cause of cardiac death indicates the need to revise the cancer register management from the standpoint of cardio-oncology. In general, there is a need to develop local protocols for screening and monitoring patients undergoing cardiotoxic chemotherapy and radiation therapy.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.23950/jcmk/11412
- https://www.clinmedkaz.org/download/a-first-approach-to-identifying-cardiotoxic-effects-of-breast-cancer-chemotherapeutic-treatment-in-11412.pdf
- OA Status
- diamond
- Cited By
- 2
- References
- 25
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4213436021
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4213436021Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.23950/jcmk/11412Digital Object Identifier
- Title
-
A first approach to identifying cardiotoxic effects of breast cancer chemotherapeutic treatment in KazakhstanWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-02-24Full publication date if available
- Authors
-
Saule Balmagambetova, Zhenisgul Tlegenova, Bekbolat Zholdin, Gulnara Kurmanalina, Iliada Talipova, Arip Koyshybaev, Ainel Urazova, Dinara Nurmanova, Olzhas Urazayev, Gulmira Sultanbekova, Kulparshan Kubenova, Mira BaspayevaList of authors in order
- Landing page
-
https://doi.org/10.23950/jcmk/11412Publisher landing page
- PDF URL
-
https://www.clinmedkaz.org/download/a-first-approach-to-identifying-cardiotoxic-effects-of-breast-cancer-chemotherapeutic-treatment-in-11412.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://www.clinmedkaz.org/download/a-first-approach-to-identifying-cardiotoxic-effects-of-breast-cancer-chemotherapeutic-treatment-in-11412.pdfDirect OA link when available
- Concepts
-
Cardiotoxicity, Medicine, Chemotherapy, Concordance, Breast cancer, Internal medicine, Cancer, Cause of death, Oncology, DiseaseTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2023: 1, 2022: 1Per-year citation counts (last 5 years)
- References (count)
-
25Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4213436021 |
|---|---|
| doi | https://doi.org/10.23950/jcmk/11412 |
| ids.doi | https://doi.org/10.23950/jcmk/11412 |
| ids.openalex | https://openalex.org/W4213436021 |
| fwci | 0.44093096 |
| type | article |
| title | A first approach to identifying cardiotoxic effects of breast cancer chemotherapeutic treatment in Kazakhstan |
| biblio.issue | 1 |
| biblio.volume | 19 |
| biblio.last_page | 35 |
| biblio.first_page | 28 |
| topics[0].id | https://openalex.org/T11535 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2705 |
| topics[0].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[0].display_name | Chemotherapy-induced cardiotoxicity and mitigation |
| topics[1].id | https://openalex.org/T11752 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9871000051498413 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Treatment and Pharmacology |
| topics[2].id | https://openalex.org/T13077 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9765999913215637 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Cancer-related cognitive impairment studies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778233292 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9313390254974365 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q2118956 |
| concepts[0].display_name | Cardiotoxicity |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.9148732423782349 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2776694085 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6833503246307373 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[2].display_name | Chemotherapy |
| concepts[3].id | https://openalex.org/C160798450 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6679324507713318 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q4230870 |
| concepts[3].display_name | Concordance |
| concepts[4].id | https://openalex.org/C530470458 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6485574245452881 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[4].display_name | Breast cancer |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5444442629814148 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C121608353 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5293931365013123 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[6].display_name | Cancer |
| concepts[7].id | https://openalex.org/C29374701 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4234277606010437 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1931388 |
| concepts[7].display_name | Cause of death |
| concepts[8].id | https://openalex.org/C143998085 |
| concepts[8].level | 1 |
| concepts[8].score | 0.41130274534225464 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[8].display_name | Oncology |
| concepts[9].id | https://openalex.org/C2779134260 |
| concepts[9].level | 2 |
| concepts[9].score | 0.0986071527004242 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[9].display_name | Disease |
| keywords[0].id | https://openalex.org/keywords/cardiotoxicity |
| keywords[0].score | 0.9313390254974365 |
| keywords[0].display_name | Cardiotoxicity |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.9148732423782349 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/chemotherapy |
| keywords[2].score | 0.6833503246307373 |
| keywords[2].display_name | Chemotherapy |
| keywords[3].id | https://openalex.org/keywords/concordance |
| keywords[3].score | 0.6679324507713318 |
| keywords[3].display_name | Concordance |
| keywords[4].id | https://openalex.org/keywords/breast-cancer |
| keywords[4].score | 0.6485574245452881 |
| keywords[4].display_name | Breast cancer |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.5444442629814148 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/cancer |
| keywords[6].score | 0.5293931365013123 |
| keywords[6].display_name | Cancer |
| keywords[7].id | https://openalex.org/keywords/cause-of-death |
| keywords[7].score | 0.4234277606010437 |
| keywords[7].display_name | Cause of death |
| keywords[8].id | https://openalex.org/keywords/oncology |
| keywords[8].score | 0.41130274534225464 |
| keywords[8].display_name | Oncology |
| keywords[9].id | https://openalex.org/keywords/disease |
| keywords[9].score | 0.0986071527004242 |
| keywords[9].display_name | Disease |
| language | en |
| locations[0].id | doi:10.23950/jcmk/11412 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210196841 |
| locations[0].source.issn | 1812-2892, 2313-1519 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1812-2892 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Journal of Clinical Medicine of Kazakhstan |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.clinmedkaz.org/download/a-first-approach-to-identifying-cardiotoxic-effects-of-breast-cancer-chemotherapeutic-treatment-in-11412.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Clinical Medicine of Kazakhstan |
| locations[0].landing_page_url | https://doi.org/10.23950/jcmk/11412 |
| locations[1].id | pmh:https://cyberleninka.ru/article/n/a-first-approach-to-identifying-cardiotoxic-effects-of-breast-cancer-chemotherapeutic-treatment-in-kazakhstan |
| locations[1].is_oa | False |
| locations[1].source | |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://cyberleninka.ru/article/n/a-first-approach-to-identifying-cardiotoxic-effects-of-breast-cancer-chemotherapeutic-treatment-in-kazakhstan |
| locations[2].id | pmh:oai:doaj.org/article:b2b702d9f25d4420a84043a58930c036 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | cc-by-sa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Ķazaķstannyṇ Klinikalyķ Medicinasy, Vol 19, Iss 1, Pp 28-35 (2022) |
| locations[2].landing_page_url | https://doaj.org/article/b2b702d9f25d4420a84043a58930c036 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5045997061 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-4080-5383 |
| authorships[0].author.display_name | Saule Balmagambetova |
| authorships[0].countries | KZ |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210130920 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[0].institutions[0].id | https://openalex.org/I4210130920 |
| authorships[0].institutions[0].ror | https://ror.org/04ehpm154 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210130920 |
| authorships[0].institutions[0].country_code | KZ |
| authorships[0].institutions[0].display_name | West Kazakhstan Marat Ospanov State Medical University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Saule Balmagambetova |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[1].author.id | https://openalex.org/A5071855625 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3707-7365 |
| authorships[1].author.display_name | Zhenisgul Tlegenova |
| authorships[1].countries | KZ |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210130920 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[1].institutions[0].id | https://openalex.org/I4210130920 |
| authorships[1].institutions[0].ror | https://ror.org/04ehpm154 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210130920 |
| authorships[1].institutions[0].country_code | KZ |
| authorships[1].institutions[0].display_name | West Kazakhstan Marat Ospanov State Medical University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Zhenisgul Tlegenova |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[2].author.id | https://openalex.org/A5009625504 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-4245-9501 |
| authorships[2].author.display_name | Bekbolat Zholdin |
| authorships[2].countries | KZ |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210130920 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[2].institutions[0].id | https://openalex.org/I4210130920 |
| authorships[2].institutions[0].ror | https://ror.org/04ehpm154 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210130920 |
| authorships[2].institutions[0].country_code | KZ |
| authorships[2].institutions[0].display_name | West Kazakhstan Marat Ospanov State Medical University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Bekbolat Zholdin |
| authorships[2].is_corresponding | True |
| authorships[2].raw_affiliation_strings | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[3].author.id | https://openalex.org/A5023519746 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-0937-2949 |
| authorships[3].author.display_name | Gulnara Kurmanalina |
| authorships[3].countries | KZ |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210130920 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[3].institutions[0].id | https://openalex.org/I4210130920 |
| authorships[3].institutions[0].ror | https://ror.org/04ehpm154 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210130920 |
| authorships[3].institutions[0].country_code | KZ |
| authorships[3].institutions[0].display_name | West Kazakhstan Marat Ospanov State Medical University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Gulnara Kurmanalina |
| authorships[3].is_corresponding | True |
| authorships[3].raw_affiliation_strings | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[4].author.id | https://openalex.org/A5041863135 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-5450-7056 |
| authorships[4].author.display_name | Iliada Talipova |
| authorships[4].countries | KZ |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210130920 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[4].institutions[0].id | https://openalex.org/I4210130920 |
| authorships[4].institutions[0].ror | https://ror.org/04ehpm154 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210130920 |
| authorships[4].institutions[0].country_code | KZ |
| authorships[4].institutions[0].display_name | West Kazakhstan Marat Ospanov State Medical University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Iliada Talipova |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[5].author.id | https://openalex.org/A5109414432 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Arip Koyshybaev |
| authorships[5].countries | KZ |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210130920 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[5].institutions[0].id | https://openalex.org/I4210130920 |
| authorships[5].institutions[0].ror | https://ror.org/04ehpm154 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210130920 |
| authorships[5].institutions[0].country_code | KZ |
| authorships[5].institutions[0].display_name | West Kazakhstan Marat Ospanov State Medical University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Arip Koyshybaev |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[6].author.id | https://openalex.org/A5088734426 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-1181-9180 |
| authorships[6].author.display_name | Ainel Urazova |
| authorships[6].countries | KZ |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210130920 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[6].institutions[0].id | https://openalex.org/I4210130920 |
| authorships[6].institutions[0].ror | https://ror.org/04ehpm154 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210130920 |
| authorships[6].institutions[0].country_code | KZ |
| authorships[6].institutions[0].display_name | West Kazakhstan Marat Ospanov State Medical University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Ainel Urazova |
| authorships[6].is_corresponding | True |
| authorships[6].raw_affiliation_strings | Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[7].author.id | https://openalex.org/A5010606750 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-7543-7587 |
| authorships[7].author.display_name | Dinara Nurmanova |
| authorships[7].countries | KZ |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210130920 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[7].institutions[0].id | https://openalex.org/I4210130920 |
| authorships[7].institutions[0].ror | https://ror.org/04ehpm154 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210130920 |
| authorships[7].institutions[0].country_code | KZ |
| authorships[7].institutions[0].display_name | West Kazakhstan Marat Ospanov State Medical University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Dinara Nurmanova |
| authorships[7].is_corresponding | True |
| authorships[7].raw_affiliation_strings | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[8].author.id | https://openalex.org/A5070709803 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-4426-342X |
| authorships[8].author.display_name | Olzhas Urazayev |
| authorships[8].countries | KZ |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210130920 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[8].institutions[0].id | https://openalex.org/I4210130920 |
| authorships[8].institutions[0].ror | https://ror.org/04ehpm154 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210130920 |
| authorships[8].institutions[0].country_code | KZ |
| authorships[8].institutions[0].display_name | West Kazakhstan Marat Ospanov State Medical University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Olzhas Urazayev |
| authorships[8].is_corresponding | True |
| authorships[8].raw_affiliation_strings | Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[9].author.id | https://openalex.org/A5001763155 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-7714-4673 |
| authorships[9].author.display_name | Gulmira Sultanbekova |
| authorships[9].countries | KZ |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210130920 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[9].institutions[0].id | https://openalex.org/I4210130920 |
| authorships[9].institutions[0].ror | https://ror.org/04ehpm154 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210130920 |
| authorships[9].institutions[0].country_code | KZ |
| authorships[9].institutions[0].display_name | West Kazakhstan Marat Ospanov State Medical University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Gulmira Sultanbekova |
| authorships[9].is_corresponding | True |
| authorships[9].raw_affiliation_strings | Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan |
| authorships[10].author.id | https://openalex.org/A5008461640 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-2018-6733 |
| authorships[10].author.display_name | Kulparshan Kubenova |
| authorships[10].countries | KZ |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210128576 |
| authorships[10].affiliations[0].raw_affiliation_string | Clinical Lab, University's Medical Center, Aktobe, Kazakhstan |
| authorships[10].institutions[0].id | https://openalex.org/I4210128576 |
| authorships[10].institutions[0].ror | https://ror.org/034p3rp25 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210128576 |
| authorships[10].institutions[0].country_code | KZ |
| authorships[10].institutions[0].display_name | Kazakhstan Medical University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Kulparshan Kubenova |
| authorships[10].is_corresponding | True |
| authorships[10].raw_affiliation_strings | Clinical Lab, University's Medical Center, Aktobe, Kazakhstan |
| authorships[11].author.id | https://openalex.org/A5000002845 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-6361-4841 |
| authorships[11].author.display_name | Mira Baspayeva |
| authorships[11].countries | KZ |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210128576 |
| authorships[11].affiliations[0].raw_affiliation_string | Chemotherapy Department, University`s Medical Center, Aktobe, Kazakhstan |
| authorships[11].institutions[0].id | https://openalex.org/I4210128576 |
| authorships[11].institutions[0].ror | https://ror.org/034p3rp25 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210128576 |
| authorships[11].institutions[0].country_code | KZ |
| authorships[11].institutions[0].display_name | Kazakhstan Medical University |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Mira Baspayeva |
| authorships[11].is_corresponding | True |
| authorships[11].raw_affiliation_strings | Chemotherapy Department, University`s Medical Center, Aktobe, Kazakhstan |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.clinmedkaz.org/download/a-first-approach-to-identifying-cardiotoxic-effects-of-breast-cancer-chemotherapeutic-treatment-in-11412.pdf |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2022-02-25T00:00:00 |
| display_name | A first approach to identifying cardiotoxic effects of breast cancer chemotherapeutic treatment in Kazakhstan |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11535 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2705 |
| primary_topic.subfield.display_name | Cardiology and Cardiovascular Medicine |
| primary_topic.display_name | Chemotherapy-induced cardiotoxicity and mitigation |
| related_works | https://openalex.org/W1601684588, https://openalex.org/W2108427450, https://openalex.org/W2160554962, https://openalex.org/W2104328188, https://openalex.org/W648938440, https://openalex.org/W4387676337, https://openalex.org/W4220795960, https://openalex.org/W2789177613, https://openalex.org/W2809246414, https://openalex.org/W2915108716 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2023 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2022 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.23950/jcmk/11412 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210196841 |
| best_oa_location.source.issn | 1812-2892, 2313-1519 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1812-2892 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Journal of Clinical Medicine of Kazakhstan |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.clinmedkaz.org/download/a-first-approach-to-identifying-cardiotoxic-effects-of-breast-cancer-chemotherapeutic-treatment-in-11412.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Clinical Medicine of Kazakhstan |
| best_oa_location.landing_page_url | https://doi.org/10.23950/jcmk/11412 |
| primary_location.id | doi:10.23950/jcmk/11412 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210196841 |
| primary_location.source.issn | 1812-2892, 2313-1519 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1812-2892 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Journal of Clinical Medicine of Kazakhstan |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.clinmedkaz.org/download/a-first-approach-to-identifying-cardiotoxic-effects-of-breast-cancer-chemotherapeutic-treatment-in-11412.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Clinical Medicine of Kazakhstan |
| primary_location.landing_page_url | https://doi.org/10.23950/jcmk/11412 |
| publication_date | 2022-02-24 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2889646458, https://openalex.org/W3147142721, https://openalex.org/W2397494371, https://openalex.org/W2800400752, https://openalex.org/W2586749137, https://openalex.org/W2613080729, https://openalex.org/W2597749648, https://openalex.org/W2529592327, https://openalex.org/W2156588691, https://openalex.org/W2105436256, https://openalex.org/W2129736317, https://openalex.org/W2115557844, https://openalex.org/W2098775844, https://openalex.org/W2130860651, https://openalex.org/W3017068829, https://openalex.org/W3010255050, https://openalex.org/W3175989007, https://openalex.org/W2791955414, https://openalex.org/W2543948044, https://openalex.org/W431041432, https://openalex.org/W2560560709, https://openalex.org/W36650246, https://openalex.org/W3123769329, https://openalex.org/W2279656465, https://openalex.org/W2948656647 |
| referenced_works_count | 25 |
| abstract_inverted_index.+ | 102 |
| abstract_inverted_index.- | 88 |
| abstract_inverted_index.a | 40, 66, 175, 194, 205, 254 |
| abstract_inverted_index.(p | 124 |
| abstract_inverted_index.-, | 105 |
| abstract_inverted_index./> | 15, 34, 62, 186, 271 |
| abstract_inverted_index.As | 0 |
| abstract_inverted_index.BC | 220 |
| abstract_inverted_index.CV | 114, 133 |
| abstract_inverted_index.In | 250 |
| abstract_inverted_index.We | 64, 173 |
| abstract_inverted_index.an | 230 |
| abstract_inverted_index.by | 9 |
| abstract_inverted_index.in | 78, 109, 120, 129, 141, 150, 163, 209, 216 |
| abstract_inverted_index.is | 7, 204, 253 |
| abstract_inverted_index.no | 118 |
| abstract_inverted_index.of | 5, 12, 23, 46, 53, 56, 68, 80, 91, 99, 112, 178, 181, 193, 207, 212, 219, 224, 227, 233, 248 |
| abstract_inverted_index.on | 43 |
| abstract_inverted_index.to | 86, 170, 197, 239, 256 |
| abstract_inverted_index.305 | 69 |
| abstract_inverted_index.The | 96, 126, 147, 188, 222 |
| abstract_inverted_index.and | 36, 58, 103, 214, 262, 268 |
| abstract_inverted_index.but | 117 |
| abstract_inverted_index.due | 85, 169 |
| abstract_inverted_index.for | 31, 260 |
| abstract_inverted_index.the | 2, 10, 26, 47, 110, 121, 142, 154, 191, 210, 217, 237, 241, 246 |
| abstract_inverted_index.two | 97 |
| abstract_inverted_index.vs. | 138, 161 |
| abstract_inverted_index.was | 74, 83, 135, 158, 167 |
| abstract_inverted_index.who | 152 |
| abstract_inverted_index.17.6 | 162 |
| abstract_inverted_index.28.1 | 136 |
| abstract_inverted_index.34.3 | 139 |
| abstract_inverted_index.34.9 | 159 |
| abstract_inverted_index.6.2% | 90 |
| abstract_inverted_index.four | 179 |
| abstract_inverted_index.from | 25, 245 |
| abstract_inverted_index.lack | 206 |
| abstract_inverted_index.need | 238, 255 |
| abstract_inverted_index.ones | 145 |
| abstract_inverted_index.rate | 123, 128, 149 |
| abstract_inverted_index.were | 94 |
| abstract_inverted_index.with | 131, 183, 229 |
| abstract_inverted_index.65.9% | 79 |
| abstract_inverted_index.There | 203 |
| abstract_inverted_index.aimed | 18 |
| abstract_inverted_index.cases | 180 |
| abstract_inverted_index.cause | 232 |
| abstract_inverted_index.death | 235 |
| abstract_inverted_index.drugs | 13, 50 |
| abstract_inverted_index.fatal | 184 |
| abstract_inverted_index.found | 65 |
| abstract_inverted_index.group | 143 |
| abstract_inverted_index.local | 258 |
| abstract_inverted_index.study | 17, 42 |
| abstract_inverted_index.there | 252 |
| abstract_inverted_index.those | 151 |
| abstract_inverted_index.total | 67 |
| abstract_inverted_index.types | 55 |
| abstract_inverted_index.used, | 51 |
| abstract_inverted_index.whose | 165 |
| abstract_inverted_index. | 272 |
| abstract_inverted_index..814). | 125 |
| abstract_inverted_index.10.5%; | 89 |
| abstract_inverted_index.</b>We | 38 |
| abstract_inverted_index.</b>to | 19 |
| abstract_inverted_index.<b>The | 16 |
| abstract_inverted_index.Aktobe | 27 |
| abstract_inverted_index.Center | 29 |
| abstract_inverted_index.EchoCG | 101, 104 |
| abstract_inverted_index.breast | 70 |
| abstract_inverted_index.cancer | 71, 242 |
| abstract_inverted_index.cases. | 72 |
| abstract_inverted_index.groups | 98 |
| abstract_inverted_index.known, | 1 |
| abstract_inverted_index.lethal | 225 |
| abstract_inverted_index.months | 137, 140, 160 |
| abstract_inverted_index.number | 111 |
| abstract_inverted_index.review | 177 |
| abstract_inverted_index.revise | 240 |
| abstract_inverted_index.showed | 106 |
| abstract_inverted_index.</b><br | 33 |
| abstract_inverted_index.Medical | 28 |
| abstract_inverted_index.absence | 192 |
| abstract_inverted_index.actions | 211 |
| abstract_inverted_index.cardiac | 234 |
| abstract_inverted_index.clarify | 20 |
| abstract_inverted_index.crucial | 199 |
| abstract_inverted_index.develop | 257 |
| abstract_inverted_index.limited | 8 |
| abstract_inverted_index.without | 76, 144, 156 |
| abstract_inverted_index.(p.005). | 146 |
| abstract_inverted_index.analysis | 189 |
| abstract_inverted_index.approach | 196 |
| abstract_inverted_index.clinical | 3 |
| abstract_inverted_index.database | 30 |
| abstract_inverted_index.detailed | 176 |
| abstract_inverted_index.detected | 113 |
| abstract_inverted_index.duration | 52 |
| abstract_inverted_index.efficacy | 4 |
| abstract_inverted_index.general, | 251 |
| abstract_inverted_index.methods: | 37 |
| abstract_inverted_index.outcomes | 226 |
| abstract_inverted_index.patients | 130, 264 |
| abstract_inverted_index.presence | 223 |
| abstract_inverted_index.process, | 49 |
| abstract_inverted_index.register | 41, 243 |
| abstract_inverted_index.survival | 122, 127, 148 |
| abstract_inverted_index.used.<br | 14 |
| abstract_inverted_index.completed | 75, 153 |
| abstract_inverted_index.essential | 44 |
| abstract_inverted_index.including | 60 |
| abstract_inverted_index.indicates | 190, 236 |
| abstract_inverted_index.outcomes, | 59 |
| abstract_inverted_index.patients, | 100 |
| abstract_inverted_index.patients. | 221 |
| abstract_inverted_index.patients; | 81 |
| abstract_inverted_index.performed | 39, 174 |
| abstract_inverted_index.protocols | 259 |
| abstract_inverted_index.radiation | 269 |
| abstract_inverted_index.recording | 198 |
| abstract_inverted_index.regarding | 201 |
| abstract_inverted_index.screening | 261 |
| abstract_inverted_index.treatment | 82, 155, 166 |
| abstract_inverted_index.difference | 108, 119 |
| abstract_inverted_index.documented | 132 |
| abstract_inverted_index.management | 218, 244 |
| abstract_inverted_index.monitoring | 263 |
| abstract_inverted_index.parameters | 45 |
| abstract_inverted_index.standpoint | 247 |
| abstract_inverted_index.systematic | 195 |
| abstract_inverted_index.undergoing | 265 |
| abstract_inverted_index.(p<.001) | 116 |
| abstract_inverted_index.<b>Material | 35 |
| abstract_inverted_index.cardiotoxic | 21, 266 |
| abstract_inverted_index.concordance | 208 |
| abstract_inverted_index.established | 231 |
| abstract_inverted_index.identified. | 95 |
| abstract_inverted_index.individuals | 164 |
| abstract_inverted_index.information | 200 |
| abstract_inverted_index.interrupted | 84, 168 |
| abstract_inverted_index.oncological | 48 |
| abstract_inverted_index.oncologists | 215 |
| abstract_inverted_index.significant | 107 |
| abstract_inverted_index.therapy.<br | 270 |
| abstract_inverted_index.(p<.001). | 172 |
| abstract_inverted_index.Chemotherapy | 73 |
| abstract_inverted_index.chemotherapy | 6, 24, 228, 267 |
| abstract_inverted_index.survival.<br | 61 |
| abstract_inverted_index.cardiologists | 213 |
| abstract_inverted_index.chemotherapy, | 54 |
| abstract_inverted_index.complications | 22, 77, 87, 93, 115, 134, 171 |
| abstract_inverted_index.cardiotoxicity | 11, 182 |
| abstract_inverted_index.cardiovascular | 92 |
| abstract_inverted_index.complications, | 57, 157 |
| abstract_inverted_index.<b>Results:</b> | 63 |
| abstract_inverted_index.cardiotoxicity. | 202 |
| abstract_inverted_index.cardio-oncology. | 249 |
| abstract_inverted_index.<b>Conclusion:</b> | 187 |
| abstract_inverted_index.outcomes. <br | 185 |
| abstract_inverted_index.2018-2019.<b> | 32 |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5008461640, https://openalex.org/A5071855625, https://openalex.org/A5023519746, https://openalex.org/A5109414432, https://openalex.org/A5041863135, https://openalex.org/A5045997061, https://openalex.org/A5070709803, https://openalex.org/A5010606750, https://openalex.org/A5088734426, https://openalex.org/A5000002845, https://openalex.org/A5009625504, https://openalex.org/A5001763155 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 12 |
| corresponding_institution_ids | https://openalex.org/I4210128576, https://openalex.org/I4210130920 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8700000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.58345181 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |